肺癌筛查市场基于(主要区域、市场参与者、规模和份额)- 预测至 2030 年

  • Report Code : TIPRE00029996
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 188
Buy Now

Lung Cancer Screening Market Size Report & Overview 2022-2030

Buy Now

 

[研究报告] 肺癌筛查市场规模预计将从 2022 年的 23.265 亿美元增至 2030 年的 43.6395 亿美元。预计 2022 年至 2030 年的复合年增长率为 8.2%。

 

 

分析师观点:

肺癌发病率的上升和政府支持的增加推动了肺癌筛查市场的扩张。随着肺癌的高发性,人们对该疾病及其相关治疗的认识也在提高。此外,政府举措提供了更好、更实惠的筛查和优惠的报销政策,预计将促进肺癌筛查市场的增长。肺癌筛查市场的主要参与者正专注于通过合作实施战略举措,以扩大其地理覆盖范围并增强满足庞大客户群的能力。例如,2021 年 11 月,GE Healthcare 和 Optellum 合作推进肺癌的精准诊断和治疗。两家公司共同寻求解决肺癌诊断中最大的挑战之一,帮助供应商确定肺结节的恶性程度:一种可能是良性或癌性的可疑病变。

 

肺癌筛查市场 - 市场概览:

肺癌筛查是一种用于检测 肺癌风险较高的健康人群的肺癌的过程。建议长期吸烟且没有任何肺癌迹象或症状的老年人进行肺癌筛查。医生使用肺部 LDCT 扫描来寻找肺癌。如果及早发现肺癌,则更有可能通过治疗治愈。 

肺癌筛查市场细分为技术、癌症类型、年龄组和最终用户。该报告对全球肺癌筛查提供了深刻见解和深入分析,重点关注市场趋势、技术进步、市场动态和主要市场参与者的竞争格局分析等参数。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

肺癌筛查市场:

Lung Cancer Screening Market: Strategic Insights

Lung Cancer Screening Market
  • CAGR
    CAGR (2022 - 2030)
    8.2%
  • Market Size 2022
    US$ 2.33 Billion
  • Market Size 2030
    US$ 4.36 Billion

Market Dynamics

GROWTH DRIVERS
  • 肺癌发病率上升
  • 政府支持力度加大
FUTURE TRENDS
  • 流动肺癌筛查车
OPPORTUNITIES
  • 结构化肺癌筛查计划

Key Players

  • Intelerad Medical Systems Incorporated
  • Nuance Communications Inc
  • GE HealthCare Technologies Inc
  • Medtronic Plc
  • Canon Medical Systems Corp
  • Koninklijke Philips NV
  • Siemens AG
  • CVS Health
  • bioAffinity Technologies Inc

Regional Overview

Regional And Country Scope
  • 北美(美国、加拿大、墨西哥)
  • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
  • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
  • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
  • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)

Market Segmentation

Segment 1癌症类型(非小细胞肺癌
  • NSCLC 和小细胞肺癌)
Segment2技术(低剂量计算机断层扫描
  • LDCT、胸部 X 光、液体活检等)
Segment3年龄组(50 岁以上和 50 岁以下)
    Segment4最终用户(医院、诊断中心等)

      肺癌筛查市场
      • Lung Cancer Screening Market
        复合年增长率(2022 - 2030 年)
        8.2%
      • 2022 年市场规模
        23.3 亿美元
      • 2030 年市场规模
        43.6 亿美元

      市场动态

      增长动力
      • 肺癌发病率上升
      • 增加政府支持
      未来的趋势
      • 流动肺癌筛查车
      机会
      • 结构化肺癌筛查计划

      关键人物;主力;重要一员

      •  
      • Intelerad 医疗系统公司
      • Nuance通讯公司
      • 通用电气医疗科技公司
      • 美敦力公司
      • 佳能医疗系统公司
      • 荷兰皇家飞利浦公司
      • 西门子股份公司
      • CVS 健康
      • bioAffinity 技术公司

      区域概况

      Lung Cancer Screening Market
      • 北美
      • 欧洲
      • 亚太
      • 南美洲和中美洲
      • 中东和非洲

      市场细分

      Lung Cancer Screening Market癌症类型
      • 非小细胞肺癌
      Lung Cancer Screening Market技术
      • 低剂量计算机断层扫描
      Lung Cancer Screening Market年龄阶层
      • 50 岁以上和 50 岁以下
      Lung Cancer Screening Market最终用户
      • 医院
      • 诊断中心
      • 其他的
      • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

       

      市场驱动因素:

       

      肺癌发病率上升推动肺癌筛查市场

      肺癌是全球主要死亡原因之一。肺癌筛查是癌症预防方法的重要组成部分。肺癌患者的预后在早期诊断时会更好,因此鼓励肺癌高风险人群进行常规检查以检测肺部是否形成癌变。根据美国癌症协会对 2023 年美国肺癌的估计,美国新增肺癌病例约 238,340 例;其中,女性 120,790 例,男性 117,550 例。此外,根据美国国家生物技术信息中心 (NCBI) 的数据,意大利每年约有 41,000 例新诊断肺癌病例和 34,000 例死亡病例。   

      根据澳大利亚癌症协会 2023 年报告,2022 年诊断出约 14,529 例新肺癌病例;其中,7,707 例为男性,6,822 例为女性。近 9% 的登记新癌症病例是在 2022 年诊断出来的,估计共有 8,664 人死于肺癌。

      因此,全球肺癌发病率的上升促使了肺癌筛查计划的启动,进而推动了肺癌筛查市场的增长。

       

      肺癌筛查市场-分部分析:

       

       

      根据癌症类型,肺癌筛查市场分为非小细胞肺癌 (NSCLC) 和小细胞肺癌。NSCLC 细分市场在 2022 年占据了更大的市场份额,预计在预测期内将以 8.0% 的复合年增长率增长。该细分市场的市场地位归因于全球 NSCLC 病例的增加。NSCLC 的发展速度比小细胞肺癌慢。它通常在诊断时扩散到患者身体的其他部位。因此,早期诊断和治疗至关重要。根据美国国家癌症研究基金会的数据,每 10 个诊断中就有近 9 个是 NSCLC。根据同一来源,大细胞未分化癌肺癌占所有 NSCLC 诊断的约 10-15%。  

       

      肺癌筛查市场-区域分析:

       

      肺癌的发病率不断上升,因此筛查对于早期发现肺癌至关重要。建议长期吸烟且没有任何肺癌相关症状的老年人进行肺癌筛查。医生使用低剂量计算机断层扫描 (LDCT) 扫描或 X 射线进行筛查。

      根据《胸腔肿瘤学杂志》2022年6月发表的一篇题​​为《德国肺癌》的文章,癌症是德国第二大死亡原因之一,占所有死亡人数的25%。在男性中,肺癌仅次于心血管疾病,占全因死亡率的6.5%。肺癌在男性和女性中的年龄标准化发病率分别为52.1和32.7(每10万人),在男性中排名第二,在女性中排名第三(分别占所有新诊断癌症的13.3%和9.4%)。癌症诊断的平均年龄为70岁(男性)和69岁(女性);52%的患者处于IV期。由于吸烟习惯的长期改变,自1990年代以来,女性和男性的发病率已经趋于一致。目前,德国有四分之一的男性(27.0%)和五分之一的女性(20.8%)经常吸烟。

      德国国家癌症计划指定器官癌症中心(肺癌中心)、肿瘤中心和综合癌症中心在德国提供一般肿瘤治疗。截至 2020 年,全国 79 家机构的 64 家肺癌中心已获得认证。此外,预计未来几年将在德国医疗保健系统中实施肺癌筛查。例如,肺部检查研究 HANSE 主要作为试点计划,以提供证据证明可以实施全面有效的肺癌筛查计划并将其整合到德国现有认证肺癌中心的基础设施中。HANSE 研究了在北德地区 5,000 名高危人群中进行控制性肺癌筛查、筛查相关心脏和肺部合并症以及评估潜在预测生物标志物的可行性。筛查由一辆移动 CT 卡车在三个经批准的肺癌中心之间轮流进行。此外,德国正在与两个研究中心一起参与欧洲“4 in the Lung Run 研究”,这是一项前瞻性试验,正在研究几项创新的筛查修改,包括个性化的招募方法、个性化的筛查间隔、改进的放射学标准等。

      因此,随着德国肺癌发病率的上升以及德国医疗保健系统中肺癌筛查的实施,肺癌筛查市场预计将增长。

       

      肺癌筛查市场-关键参与者分析:

       

      肺癌筛查市场分析涉及对 Intelerad Medical Systems Incorporated、Nuance Communications Inc、GE HealthCare Technologies Inc、Medtronic Plc、Canon Medical Systems Corp、Koninklijke Philips NV、Siemens AG、Aetna Inc、bioAffinity Technologies, Inc. 和 LungLife AI, Inc. 等参与者的研究。在肺癌筛查市场的参与者中,西门子股份公司和美敦力公司凭借提供多样化的产品组合成为排名前两位的参与者。

       

      肺癌筛查市场报告范围

      报告属性细节
      2022 年市场规模23.3亿美元
      2030 年的市场规模43.6亿美元
      全球复合年增长率(2022 - 2030 年)8.2%
      历史数据2020-2021
      预测期2023-2030
      涵盖的领域按癌症类型
      • 非小细胞肺癌
      按技术分类
      • 低剂量计算机断层扫描
      按年龄组
      • 50 岁以上和 50 岁以下
      按最终用户
      • 医院
      • 诊断中心
      • 其他的
      覆盖地区和国家北美
      • 我们
      • 加拿大
      • 墨西哥
      欧洲
      • 英国
      • 德国
      • 法国
      • 俄罗斯
      • 意大利
      • 欧洲其他地区
      亚太
      • 中国
      • 印度
      • 日本
      • 澳大利亚
      • 亚太其他地区
      南美洲和中美洲
      • 巴西
      • 阿根廷
      • 南美洲和中美洲其他地区
      中东和非洲
      • 南非
      • 沙特阿拉伯
      • 阿联酋
      • 中东和非洲其他地区
      市场领导者和主要公司简介
      •  
      • Intelerad 医疗系统公司
      • Nuance通讯公司
      • 通用电气医疗科技公司
      • 美敦力公司
      • 佳能医疗系统公司
      • 荷兰皇家飞利浦公司
      • 西门子股份公司
      • CVS 健康
      • bioAffinity 技术公司
      • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

       

       

      肺癌筛查市场 - 最新发展: 

       

      肺癌筛查市场中的公司普遍采用并购等无机和有机策略。以下列出了一些近期的关键市场发展:

      • 2022年6月,荷兰皇家飞利浦公司与Biodesix公司合作,将Biodesix的Nodify Lung基于血液的肺结节风险评估检测结果纳入飞利浦Lung Cancer Orchestrator肺癌患者管理系统。
      • 2022 年 8 月,Intelerad Medical Systems 收购了 PenRad Technologies, Inc.,这是一家提高乳房成像和肺部筛查效率的软件提供商。此次收购扩大了 Intelerad 的乳房 X 线摄影和肺部分析产品范围,优化了放射科医生的工作流程并改善了患者的健康状况。
      • 2021年5月,泛生子控股有限公司与西门子医疗在全国医疗器械博览会上达成合作,推动泛生子S5平台及肺癌8基因体外诊断检测在中国医院的规模化应用,为非小细胞肺癌患者提供高效、精准的个性化诊疗指导。 

      Lung Cancer Screening Market Report Scope

      Report Attribute Details
      Market size in US$ 2.33 Billion
      Market Size by US$ 4.36 Billion
      Global CAGR 8.2%
      Historical Data 2020-2021
      Forecast period 2023-2030
      Segments Covered By 癌症类型(非小细胞肺癌
      • NSCLC 和小细胞肺癌)
      By 技术(低剂量计算机断层扫描
      • LDCT、胸部 X 光、液体活检等)
      By 年龄组(50 岁以上和 50 岁以下)
      By 最终用户(医院、诊断中心等)
      Regions and Countries Covered 北美(美国、加拿大、墨西哥)
      • 北美(美国、加拿大、墨西哥)
      欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
      • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
      亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
      • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
      南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
      • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
      中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
      • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
      Market leaders and key company profiles
    • Intelerad Medical Systems Incorporated
    • Nuance Communications Inc
    • GE HealthCare Technologies Inc
    • Medtronic Plc
    • Canon Medical Systems Corp
    • Koninklijke Philips NV
    • Siemens AG
    • CVS Health
    • bioAffinity Technologies Inc
    • Report Coverage
      Report Coverage

      Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

      Segment Covered
      Segment Covered

      This text is related
      to segments covered.

      Regional Scope
      Regional Scope

      North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

      Country Scope
      Country Scope

      This text is related
      to country scope.

      Frequently Asked Questions


      What are the driving factors for the Lung cancer screening market across the globe?

      The factors such as rising lung cancer incidence and increasing government support drive the market growth. However, high cost of lung screening tests hinders the market growth.

      What are the opportunities for lung cancer screening market entrants?

      Structured lung cancer screening program is likely to fuel the market growth in the coming years.

      Which is the most influencing segment growing in the lung cancer screening market report?

      Small cell lung cancer segment is growing in the lung cancer screening market.

      What is Lung cancer screening?

      Lung cancer screening is a process used to detect lung cancer in otherwise healthy people with a high risk of lung cancer. Lung cancer screening is recommended for older adults who are long time smokers and who don't have any signs or symptoms of lung cancer. Doctors use a low-dose computerized tomography (LDCT) scan of the lungs to look for lung cancer. If lung cancer is detected early, it's more likely to be cured with treatment.

      Who are the major players in the lung cancer screening market?

      The lung cancer screening market majorly consists of the players such as Intelerad Medical Systems Incorporated, Nuance Communications Inc, GE HealthCare Technologies Inc, Medtronic Plc, Canon Medical Systems Corp, Koninklijke Philips NV, Siemens AG, Aetna Inc, bioAffinity Technologies, Inc., and LungLife AI, Inc., among others.

      What are the key trends in the lung cancer screening market?

      Mobile lung cancer screening truck in lung cancer screening market is likely to trend the market growth in the coming years.

      The List of Companies - Lung Cancer Screening Market

      1. Intelerad Medical Systems Incorporated
      2. Nuance Communications Inc
      3. GE HealthCare Technologies Inc
      4. Medtronic Plc
      5. Canon Medical Systems Corp
      6. Koninklijke Philips NV
      7. Siemens AG
      8. CVS Health
      9. bioAffinity Technologies, Inc.
      10. LungLife AI, Inc.

      The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

      1. Data Collection and Secondary Research:

      As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

      Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

      1. Primary Research:

      The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

      For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

      A typical research interview fulfils the following functions:

      • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
      • Validates and strengthens in-house secondary research findings
      • Develops the analysis team’s expertise and market understanding

      Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

      • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
      • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

      Below is the breakup of our primary respondents by company, designation, and region:

      Research Methodology

      Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

      1. Data Analysis:

      Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

      • Macro-Economic Factor Analysis:

      We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

      • Country Level Data:

      Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

      • Company Profile:

      The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

      • Developing Base Number:

      Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

      1. Data Triangulation and Final Review:

      The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

      We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

      We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

      Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

      Trends and growth analysis reports related to Medical Device : READ MORE..